Clinical Trial Update: A Study on the Regenerative Treatment of Tympanic Membrane With NPC-18 and FBG-18 [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating regenerative treatment of tympanic membrane perforation using NPC-18 and FBG-18 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tympanic Membrane Perforation

Drugs mentioned

• FBG-18
• NPC-18

Snippet

Sponsor: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | Conditions: Tympanic Membrane Perforation | Phase 3 | Status: COMPLETED